Cascadian Therapeutics, Inc. (NASDAQ:CASC) represented a move of 0 percent or $-0.01 per share and closed its previous day trading session at $10. 684165 Shares were traded in the last trading session with an Average Volume of 886.6 Million Shares. The stock currently has a Market Capitalization of 504.6 Million.
Cascadian Therapeutics, Inc. is a biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. The company’s product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor which is in preclinical trial stage. Cascadian Therapeutics, Inc., formerly known as Oncothyreon Inc., is headquartered in Seattle, Washington.
The stock traded between $ 3.18 and $10.21 over 1-Year time period showing its price to sales ratio of 0. Cascadian Therapeutics, Inc. (NASDAQ:CASC) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $90.72 and 200-Day Simple Moving Average of $132.85. Its Price to Free Cash Flow is 0 and Price to Book of 4.05.
Analyst’s recommended the stock as 2.6 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Cascadian Therapeutics, Inc. (NASDAQ:CASC) reported its Actual EPS of $-0.28/share. The analysts offering Earnings Estimates for the company were believing that Cascadian Therapeutics, Inc. could bring EPS of $-0.29/share. The difference between Actual EPS and Estimated EPS was 0.01 Percent. Thus showing an Earnings Surprise of 3.4 Percent.
Arlington Asset Investment Corp. (NYSE:AI)
In the last trading session, Arlington Asset Investment Corp. (NYSE:AI) added its value by 0.37% closing at the price of $10.93. The stock currently has market capitalization of 314.57 Million, with average volume of 514.52 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Arlington Asset Investment Corp. (NYSE:AI) is showing beta of 0.67. This particular value of beta suggests that Arlington Asset Investment Corp. (NYSE:AI) has historically moved 67% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Arlington Asset Investment Corp. (NYSE:AI) is at $0.58.
The stock currently has RSI of 45.85. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Arlington Asset Investment Corp. is a principal investment firm that currently invests primarily in mortgage-related and other assets.
Arlington Asset Investment Corp. (NYSE:AI) topped its 52-week high price of $15.17 on 04/26/17 and 52-Week Low Price of $ 9.90 on 02/06/18. The Stock currently has P/E (price to earnings ttm) of 18.91 and Weekly volatility of 3.07% and monthly volatility of 2.62% respectively.